Better therapy for patients with heart failure and atrial fibrillation (CABA-HFPEF-DZHK27 trial)

The study "CABA-HFPEF-DZHK27" (CAtheter-Based Ablation of atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) is aiming for a better therapy for patients with heart failure and atrial fibrillation. Charité (Berlin, Germany) has the overall responsibility for the study. This trial is supported by German Centre for Cardiovascular Research (DZHK). Further information can be found in the press release (german only).